
Children with zzso cell disease zzso and strokes receive blood zzso therapy for secondary stroke zzso despite this, approximately zzso experience second overt zzso Given this rate of second overt strokes and the clinical significance of silent cerebral zzso we tested the hypothesis that silent cerebral zzso occur among children with zzso being zzso for secondary stroke zzso A prospective cohort enrolled children with zzso and overt strokes at 7 academic zzso zzso resonance imaging and magnetic resonance zzso of the brain were scheduled approximately every 1 to 2 years; studies were reviewed by a panel of zzso zzso criteria included regularly scheduled blood zzso zzso Forty children were zzso mean zzso zzso S concentration was zzso Progressive cerebral zzso occurred in zzso (18 of 40 zzso while receiving chronic blood zzso zzso 7 had second overt strokes and 11 had new silent cerebral zzso zzso cerebral zzso was associated with new cerebral zzso zzso or zzso relative risk zzso zzso zzso confidence zzso zzso P zzso zzso Children with zzso and overt strokes receiving regular blood zzso therapy experience silent cerebral zzso at a higher rate than previously zzso Additional therapies are needed for secondary stroke prevention in children with zzso 

